J.A. Burgers

799 total citations
25 papers, 566 citations indexed

About

J.A. Burgers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J.A. Burgers has authored 25 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in J.A. Burgers's work include Pleural and Pulmonary Diseases (9 papers), Occupational and environmental lung diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). J.A. Burgers is often cited by papers focused on Pleural and Pulmonary Diseases (9 papers), Occupational and environmental lung diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). J.A. Burgers collaborates with scholars based in Netherlands, United States and Belgium. J.A. Burgers's co-authors include Paul Baas, Jan P. van Meerbeeck, Hendrik Koffijberg, Bas A.J.M. de Mol, Karel G.M. Moons, R.J. van Klaveren, W. J. Mooi, C. Manegold, Maja J.A. de Jonge and J M W van Haarst and has published in prestigious journals such as Blood, Biochemical Journal and British Journal of Cancer.

In The Last Decade

J.A. Burgers

24 papers receiving 553 citations

Peers

J.A. Burgers
Han Yang China
Sarah Skeoch United Kingdom
Daizo Kishino Japan
Yoshimi Otani Japan
Jonathan Benzaquen France
H. G. Velcovsky Germany
Aya Nakaya Japan
Olsi Gjyshi United States
Maurizio Mezzetti Italy
Han Yang China
J.A. Burgers
Citations per year, relative to J.A. Burgers J.A. Burgers (= 1×) peers Han Yang

Countries citing papers authored by J.A. Burgers

Since Specialization
Citations

This map shows the geographic impact of J.A. Burgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Burgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Burgers more than expected).

Fields of papers citing papers by J.A. Burgers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Burgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Burgers. The network helps show where J.A. Burgers may publish in the future.

Co-authorship network of co-authors of J.A. Burgers

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Burgers. A scholar is included among the top collaborators of J.A. Burgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Burgers. J.A. Burgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Broek, Daan van den, Willemijn S.M.E. Theelen, Wieneke A. Buikhuisen, et al.. (2024). Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort. Lung Cancer. 198. 107972–107972. 3 indexed citations
3.
4.
Turenhout, Sietze T. van, Pétur Snæbjörnsson, Sofie Wilgenhof, et al.. (2019). Cytomegalovirus in Steroid-Refractory Immune Checkpoint Inhibition–Related Colitis. Journal of Thoracic Oncology. 15(1). e15–e20. 7 indexed citations
5.
Nuland, Merel van, M. J. X. Hillebrand, Hilde Rosing, et al.. (2017). Ultra-sensitive LC–MS/MS method for the quantification of gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma for a microdose clinical trial. Journal of Pharmaceutical and Biomedical Analysis. 151. 25–31. 16 indexed citations
6.
Dingemans, Anne‐Marie C., Harry J.M. Groen, Gerarda J.M. Herder, et al.. (2015). A randomized phase II study comparing paclitaxel–carboplatin–bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170). Annals of Oncology. 26(11). 2286–2293. 30 indexed citations
7.
8.
Koffijberg, Hendrik, J.A. Burgers, Paul Baas, et al.. (2012). Prognosis and prognostic factors of patients with mesothelioma: a population-based study. British Journal of Cancer. 107(1). 161–164. 39 indexed citations
9.
Rosing, Hilde, et al.. (2012). Quantitative Determination of Erlotinib And O -Desmethyl Erlotinib in Human Edta Plasma And Lung Tumor Tissue. Bioanalysis. 4(21). 2563–2577. 12 indexed citations
10.
Schaake, Eva, et al.. (2011). Markers for the non-invasive diagnosis of mesothelioma: a systematic review. British Journal of Cancer. 104(8). 1325–1333. 51 indexed citations
11.
Koning, C.C.E., Mieke J. Aarts, H. Struikmans, et al.. (2011). Mapping Use of Radiotherapy for Patients with Non-small Cell Lung Cancer in the Netherlands between 1997 and 2008. Clinical Oncology. 24(2). e46–e53. 10 indexed citations
12.
Joerger, Markus, J.A. Burgers, Paul Baas, et al.. (2011). Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. Cancer Chemotherapy and Pharmacology. 69(1). 25–33. 26 indexed citations
13.
Burgers, J.A., Peter W.A. Kunst, Marijn Koolen, et al.. (2008). Pleural drainage and pleurodesis: implementation of guidelines in four hospitals. European Respiratory Journal. 32(5). 1321–1327. 28 indexed citations
14.
Kappers, Ingrid, J. Belderbos, J.A. Burgers, et al.. (2007). Non-small cell lung carcinoma of the superior sulcus: Favourable outcomes of combined modality treatment in carefully selected patients. Lung Cancer. 59(3). 385–390. 20 indexed citations
15.
Burgers, J.A., et al.. (2006). [Chronic indwelling pleural catheter for malignant pleural effusion in 25 patients].. PubMed. 150(29). 1618–23. 13 indexed citations
16.
Baas, Paul, J. Belderbos, Suresh Senan, et al.. (2006). Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study. British Journal of Cancer. 94(5). 625–630. 71 indexed citations
17.
Hegmans, Joost P., Katarina Radošević, Jane S.A. Voerman, et al.. (2002). A model system for optimising the selection of membrane antigen-specific human antibodies on intact cells using phage antibody display technology. Journal of Immunological Methods. 262(1-2). 191–204. 5 indexed citations
18.
Haarst, J M W van, Paul Baas, C. Manegold, et al.. (2002). Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. British Journal of Cancer. 86(3). 342–345. 115 indexed citations
19.
Burgers, J.A., et al.. (1993). Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.. PubMed. 7(2). 135–49. 6 indexed citations
20.
Burgers, J.A., et al.. (1986). Selection byGenetic Transformation ofaSaccharomyces cerevisiae MutantDefective fortheNuclear Uracil-DNA-Glycosylase. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Yang Breakdown of academic impact, for papers by Sarah Skeoch Breakdown of academic impact, for papers by Daizo Kishino Breakdown of academic impact, for papers by Yoshimi Otani Breakdown of academic impact, for papers by Jonathan Benzaquen Breakdown of academic impact, for papers by H. G. Velcovsky Breakdown of academic impact, for papers by Aya Nakaya Breakdown of academic impact, for papers by Olsi Gjyshi Breakdown of academic impact, for papers by Maurizio Mezzetti
Rankless by CCL
2026